Indaptus Therapeutics implements 1-for-28 reverse stock split effective June 26, 2025

Indaptus Therapeutics, Inc.

Reverse stock split at ratio of 1-for-28 effective after market close on June 26, 2025.
Trading on split-adjusted basis begins June 27, 2025; new CUSIP 45339J 204.
Purpose is to regain Nasdaq continued listing compliance and attract institutional investors.
Outstanding shares reduced from ~16 million to ~572 thousand; no change in authorized shares.
Proportionate adjustments made to options, warrants; fractional shares paid in cash.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Indaptus Therapeutics, Inc.: Filed Certificate of Amendment to effect a 1-for-28 reverse stock split of common stock (effective 2025-06-26).

Change: charter amendment
Effective: 2025-06-26

Exact text from the filing

on June 26, 2025, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split, which became effective as of 5:00 p.m. Eastern Time on June 26, 2025.

View on SEC.gov

Browse all governance changes →

Indaptus Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-016694

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.